| Code | 7762E |
| MA number | EU/1/24/1843/002 |
| Product Form: | con inf 1x4 ml/80 mg (liek.inj.skl.) |
| MA Status: | Ex - Conditional centralised marketing authorisation |
| Type of procedure: | EU |
| MAH, country: | Regeneron Ireland Designated Activity Company (DAC), Ireland |
| Therapeutic Class: | 44 - CYTOSTATICA |
| Shelf life: | 36 |
| Container: | glass vial |
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 22.08.2024 |
| Validity: | 22.08.2025 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | Yes |
| Data update: | 15.10.2024 |
